Natalia Lagunas

Dr. Natalia Lagunas

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Hormones and Behavior
Verified
Journal Article
Closed access
NLNatalia Lagunas
Natalia Lagunas
ICIsabel Calmarza-Font
Isabel Calmarza-Font
YDYolanda Diz-Chaves
Yolanda Diz-Chaves
LGLuis Miguel Garcia-Segura
Luis Miguel Garcia-Segura

11 November 2010 in Journal of Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
M.-A. ArevaloM.-A. Arevalo
M.-A. Arevalo
MSMaría Santos-Galindo
María Santos-Galindo
NLNatalia Lagunas
Natalia Lagunas
IAIñigo Azcoitia
Iñigo Azcoitia
LGLuis Miguel Garcia-Segura
Luis Miguel Garcia-Segura
Selective estrogen receptor modulators (SERMs), used for the treatment of breast cancer, osteoporosis, and menopausal symptoms, affect the nervous system. Some SERMs trigger neuroprotective mechanisms and reduce neural damage in different experimental models of neural trauma, brain inflammation, neurodegenerative diseases, cognitive impairment, and affective disorders. New SERMs with specific actions on neurons and glial cells may represent promising therapeutic tools for the brain.

1 November 2010 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
CGCristina García-Cáceres
Cristina García-Cáceres
NLNatalia Lagunas
Natalia Lagunas
ICIsabel Calmarza-Font
Isabel Calmarza-Font
IAIñigo Azcoitia
Iñigo Azcoitia
YDYolanda Diz-Chaves
Yolanda Diz-Chaves
JCJulie Ann Chowen
Julie Ann Chowen

19 January 2022 in World Journal of Psychiatry
Verified
Journal Article
Open access
VFVeronica Fernandez-Rodrigues
Veronica Fernandez-Rodrigues
YSYolanda Sanchez-Carro
Yolanda Sanchez-Carro
NLNatalia Lagunas
Natalia Lagunas
LRLaura Alejandra Rico-Uribe
Laura Alejandra Rico-Uribe
APAndres Pemau
Andres Pemau
ATAlejandro de la Torre-Luque
Alejandro de la Torre-Luque
Risk factors for suicidal behaviour in late-life depression: A systematic review

21 April 2017 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
DGDaniela Grassi
Daniela Grassi
HFHenriette Franz
Henriette Franz
RVRiccardo Vezzali
Riccardo Vezzali
PBPatrick Bovio
Patrick Bovio
SHStefanie Heidrich
Stefanie Heidrich
TVTanja Vogel
Tanja Vogel
Neuronal activity is altered in several neurological and psychiatric diseases. Upon depolarization not only neurotransmitters are released but also cytokines and other activators of signaling cascades. Unraveling their complex implication in transcriptional control in receiving cells will contribute to understand specific central nervous system (CNS) pathologies and will be of therapeutically interest. In this study we depolarized mature hippocampal neurons in vitro using KCl and revealed increased release not only of brain-derived neurotrophic factor (BDNF) but also of transforming growth factor beta (TGFB). Neuronal activity together with BDNF and TGFB controls transcription of DNA modifying enzymes specifically members of the DNA-damage-inducible (Gadd) family, Gadd45a, Gadd45b, and Gadd45g. MeDIP followed by massive parallel sequencing and transcriptome analyses revealed less DNA methylation upon KCl treatment. Psychiatric disorder-related genes, namely Tshz1, Foxn3, Jarid2, Per1, Map3k5, and Arc are transcriptionally activated and demethylated upon neuronal activation. To analyze whether misexpression of Gadd45 family members are associated with psychiatric diseases, we applied unpredictable chronic mild stress (UCMS) as established model for depression to mice. UCMS led to reduced expression of Gadd45 family members. Taken together, our data demonstrate that Gadd45 family members are new putative targets for UCMS treatments.

21 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
BPBarbara Planchez
Barbara Planchez
NLNatalia Lagunas
Natalia Lagunas
AGAnne-Marie Le Guisquet
Anne-Marie Le Guisquet
MLMarc Legrand
Marc Legrand
ASAlexandre Surget
Alexandre Surget
CBCatherine Belzung
Catherine Belzung
Many studies evaluated the functional role of adult hippocampal neurogenesis (AHN) and its key role in cognitive functions and mood regulation. The effects of promoting AHN on the recovery of stress-induced symptoms have been well studied, but its involvement in stress resilience remains elusive. We used a mouse model enabling us to foster AHN before the exposure to unpredictable chronic mild stress (UCMS) to evaluate the potential protective effects of AHN on stress, assessing the depressive-like phenotype and executive functions. For this purpose, an inducible transgenic mouse model was used to delete the pro-apoptotic gene Bax from neural progenitors four weeks before UCMS, whereby increasing the survival of adult-generated neurons. Our results showed that UCMS elicited a depressive-like phenotype, highlighted by a deteriorated coat state, a higher immobility duration in the tail suspension test (TST), and a delayed reversal learning in a water maze procedure. Promoting AHN before UCMS was sufficient to prevent the development of stressed-induced behavioral changes in the TST and the water maze, reflecting an effect of AHN on stress resilience. Taken together, our data suggest that increasing AHN promotes stress resilience on some depressive-like symptoms but also in cognitive symptoms, which are often observed in MD.